Partners Moto Araki, Todd Liao, Joo Khin Ng, Billy Wong, and Nancy Yamaguchi wrote an article for Pharma Focus Asia discussing the impact of COVID-19 on the Asian life sciences sector, and look more closely at current M&A trends in China, Japan, Hong Kong and Singapore markets.